Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | chromobox protein, putative | 0.0044 | 0.1504 | 0.0969 |
Echinococcus multilocularis | chromobox protein 1 | 0.0073 | 0.5152 | 0.197 |
Toxoplasma gondii | thioredoxin reductase | 0.0111 | 1 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0111 | 1 | 1 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.0047 | 0.1839 | 0.0817 |
Echinococcus multilocularis | chromobox protein 1 | 0.0073 | 0.5152 | 0.197 |
Brugia malayi | Thioredoxin reductase | 0.0111 | 1 | 1 |
Trichomonas vaginalis | chromobox protein, putative | 0.0073 | 0.5152 | 1 |
Trichomonas vaginalis | chromobox protein, putative | 0.0044 | 0.1504 | 0.0969 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0064 | 0.3963 | 0.3207 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0064 | 0.3963 | 0.5 |
Echinococcus granulosus | chromobox protein 1 | 0.0073 | 0.5152 | 0.197 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0044 | 0.1504 | 1 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0064 | 0.3963 | 0.5 |
Leishmania major | trypanothione reductase | 0.0111 | 1 | 1 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0064 | 0.3963 | 0.5 |
Plasmodium falciparum | glutathione reductase | 0.0111 | 1 | 1 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.0047 | 0.1839 | 0.0817 |
Schistosoma mansoni | chromobox protein | 0.0073 | 0.5152 | 0.197 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0064 | 0.3963 | 0.7056 |
Trichomonas vaginalis | chromobox protein, putative | 0.0073 | 0.5152 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.0111 | 1 | 1 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0064 | 0.3963 | 0.5 |
Plasmodium vivax | glutathione reductase, putative | 0.0111 | 1 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.0111 | 1 | 1 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0111 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0064 | 0.3963 | 0.5 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0111 | 1 | 1 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0064 | 0.3963 | 0.5 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0111 | 1 | 1 |
Brugia malayi | Heterochromatin protein 1 | 0.0073 | 0.5152 | 0.4545 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0111 | 1 | 1 |
Trypanosoma brucei | trypanothione reductase | 0.0111 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.1113 | 0.1113 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0111 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0064 | 0.3963 | 0.5 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0041 | 0.1113 | 0.7399 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0064 | 0.3963 | 0.5 |
Loa Loa (eye worm) | heterochromatin protein 1 | 0.0073 | 0.5152 | 0.5152 |
Treponema pallidum | NADH oxidase | 0.0064 | 0.3963 | 0.5 |
Echinococcus granulosus | chromobox protein 1 | 0.0073 | 0.5152 | 0.197 |
Schistosoma mansoni | chromobox protein | 0.0073 | 0.5152 | 0.197 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0064 | 0.3963 | 0.7056 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | > 10 uM | Inhibitory concentration against T cell proliferation using concanavalin A stimulated mice spleen cells | ChEMBL. | 11229767 |
IC50 (functional) | > 30 uM | Inhibitory concentration against TNF-alpha production from human peripheral blood mononuclear cells stimulated by LPS | ChEMBL. | 11229767 |
IC50 (functional) | > 30 uM | Inhibitory concentration against growth of LPS stimulated human peripheral blood mononuclear cells | ChEMBL. | 11229767 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.